Physician profile
Ratnesh Nandan Mehra
NPI 1609138841
$16,971.94
in general payments reported to CMS, 2019-2025
29 companies · $3,369 in 2025
The $3,369 reported for 2025 was more than what 76% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,612 · 2020: $391 · 2021: $2,923 · 2022: $3,364 · 2023: $1,979 · 2024: $2,334 · 2025: $3,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,105 · Debt Forgiveness: $1,490 · Travel and Lodging: $47.18 · Education: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,104.63 |
| Debt Forgiveness | $1,490.00 |
| Travel and Lodging | $47.18 |
| Education | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,726.76 | 2021-2025 | Mazor X System, Catalyft Pl Expandable Interbody System, Unid_pass |
| Medtronic USA, INC. | $2,486.18 | 2019-2020 | |
| Acera Surgical, INC. | $1,490.00 | 2025 | Restrata Wound Matrix |
| Boston Scientific Corporation | $563.22 | 2022-2023 | |
| Mis Technologies, LLC | $516.54 | 2021 | |
| Stryker Corporation | $331.95 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $283.39 | 2019 | |
| Intrinsic Therapeutics | $193.77 | 2022 | |
| Nuvasive, INC. | $192.99 | 2021-2022 | |
| Kerecis Limited | $187.14 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Augmedics INC. | $173.01 | 2024 | Xvision |
| Alphatec Spine, INC | $122.19 | 2022 | |
| Globus Medical, INC. | $100.10 | 2019 | |
| Aesculap, INC. | $92.37 | 2024 | M.Blue |
| Longeviti Neuro Solutions INC | $70.00 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $66.00 | 2022 | |
| Depuy Synthes Sales INC. | $62.81 | 2019-2020 | |
| Si-Bone, INC. | $44.90 | 2019 | |
| Innovasis INC | $41.33 | 2022 | |
| Csl Behring | $40.00 | 2024 | Kcentra |
| Integra Lifesciences Corporation | $38.47 | 2022 | |
| Djo, LLC | $37.16 | 2019-2025 | Cmf |
| Orthofix Medical, INC. | $25.66 | 2025 | Cervical-Stim |
| Abbvie INC. | $23.66 | 2025 | |
| Saluda Medical Americas, INC. | $19.19 | 2024 | Evoke |
| Mimedx Group, INC. | $16.73 | 2025 | |
| Spineology INC. | $14.14 | 2022 | |
| Relievant Medsystems, INC. | $6.65 | 2020 | |
| Spinal Elements, INC. | $5.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ratnesh Mehra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.